[Influenza and pneumococcal vaccination in adults].
Identifieur interne : 000415 ( Main/Corpus ); précédent : 000414; suivant : 000416[Influenza and pneumococcal vaccination in adults].
Auteurs : T. Weinke ; W. GüthoffSource :
- Deutsche medizinische Wochenschrift (1946) [ 1439-4413 ] ; 2009.
English descriptors
- KwdEn :
- Adult, Aged, Antibody Formation, Bacteremia (epidemiology), Bacteremia (immunology), Bacteremia (prevention & control), Germany, Humans, Influenza Vaccines (administration & dosage), Influenza, Human (epidemiology), Influenza, Human (immunology), Influenza, Human (mortality), Middle Aged, Physician-Patient Relations, Pneumococcal Vaccines (administration & dosage), Seasons.
- MESH :
- chemical , administration & dosage : Influenza Vaccines, Pneumococcal Vaccines.
- geographic : Germany.
- epidemiology : Bacteremia, Influenza, Human.
- immunology : Bacteremia, Influenza, Human.
- mortality : Influenza, Human.
- prevention & control : Bacteremia.
- Adult, Aged, Antibody Formation, Humans, Middle Aged, Physician-Patient Relations, Seasons.
Abstract
Seasonal influenza causes yearly increased morbidity and mortality especially in older adults and patients with a comorbidity. Vaccination coverage in Germany reaches 60 % in the age group of persons over 60 years, but fails to reach the WHO target of 75 %. Improved immunogenicity of vaccines is necessary because of the occurrence of immunosenescence. This can be achieved by improved adjuvants or by new routes of application like the intradermal vaccination which produces higher antibody levels. Invasive pneumococcal infections cause up to 10000 deaths in Germany every year. The polysaccharide vaccine prevents 60 - 80 % of invasive bacteremic pneumococcal infections and reduces the mortality and severity of invasive courses. Only 20 % of the target group is vaccinated: German physicians should stress the need for pneumococcal vaccination.
DOI: 10.1055/s-0029-1220215
PubMed: 19353477
Links to Exploration step
pubmed:19353477Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Influenza and pneumococcal vaccination in adults].</title><author><name sortKey="Weinke, T" sort="Weinke, T" uniqKey="Weinke T" first="T" last="Weinke">T. Weinke</name><affiliation><nlm:affiliation>Zentrum für Innere Medizin, Klinikum Ernst von Bergmann, Potsdam. tweinke@klinikumevb.de</nlm:affiliation></affiliation></author><author><name sortKey="Guthoff, W" sort="Guthoff, W" uniqKey="Guthoff W" first="W" last="Güthoff">W. Güthoff</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2009">2009</date><idno type="RBID">pubmed:19353477</idno><idno type="pmid">19353477</idno><idno type="doi">10.1055/s-0029-1220215</idno><idno type="wicri:Area/Main/Corpus">000415</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000415</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[Influenza and pneumococcal vaccination in adults].</title><author><name sortKey="Weinke, T" sort="Weinke, T" uniqKey="Weinke T" first="T" last="Weinke">T. Weinke</name><affiliation><nlm:affiliation>Zentrum für Innere Medizin, Klinikum Ernst von Bergmann, Potsdam. tweinke@klinikumevb.de</nlm:affiliation></affiliation></author><author><name sortKey="Guthoff, W" sort="Guthoff, W" uniqKey="Guthoff W" first="W" last="Güthoff">W. Güthoff</name></author></analytic><series><title level="j">Deutsche medizinische Wochenschrift (1946)</title><idno type="eISSN">1439-4413</idno><imprint><date when="2009" type="published">2009</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Aged</term><term>Antibody Formation</term><term>Bacteremia (epidemiology)</term><term>Bacteremia (immunology)</term><term>Bacteremia (prevention & control)</term><term>Germany</term><term>Humans</term><term>Influenza Vaccines (administration & dosage)</term><term>Influenza, Human (epidemiology)</term><term>Influenza, Human (immunology)</term><term>Influenza, Human (mortality)</term><term>Middle Aged</term><term>Physician-Patient Relations</term><term>Pneumococcal Vaccines (administration & dosage)</term><term>Seasons</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Influenza Vaccines</term><term>Pneumococcal Vaccines</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>Germany</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Bacteremia</term><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Bacteremia</term><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Bacteremia</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Antibody Formation</term><term>Humans</term><term>Middle Aged</term><term>Physician-Patient Relations</term><term>Seasons</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Seasonal influenza causes yearly increased morbidity and mortality especially in older adults and patients with a comorbidity. Vaccination coverage in Germany reaches 60 % in the age group of persons over 60 years, but fails to reach the WHO target of 75 %. Improved immunogenicity of vaccines is necessary because of the occurrence of immunosenescence. This can be achieved by improved adjuvants or by new routes of application like the intradermal vaccination which produces higher antibody levels. Invasive pneumococcal infections cause up to 10000 deaths in Germany every year. The polysaccharide vaccine prevents 60 - 80 % of invasive bacteremic pneumococcal infections and reduces the mortality and severity of invasive courses. Only 20 % of the target group is vaccinated: German physicians should stress the need for pneumococcal vaccination.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">19353477</PMID><DateCompleted><Year>2009</Year><Month>05</Month><Day>14</Day></DateCompleted><DateRevised><Year>2009</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1439-4413</ISSN><JournalIssue CitedMedium="Internet"><Volume>134 Suppl 2</Volume><PubDate><Year>2009</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Deutsche medizinische Wochenschrift (1946)</Title><ISOAbbreviation>Dtsch. Med. Wochenschr.</ISOAbbreviation></Journal><ArticleTitle>[Influenza and pneumococcal vaccination in adults].</ArticleTitle><Pagination><MedlinePgn>S82-5</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1055/s-0029-1220215</ELocationID><Abstract><AbstractText>Seasonal influenza causes yearly increased morbidity and mortality especially in older adults and patients with a comorbidity. Vaccination coverage in Germany reaches 60 % in the age group of persons over 60 years, but fails to reach the WHO target of 75 %. Improved immunogenicity of vaccines is necessary because of the occurrence of immunosenescence. This can be achieved by improved adjuvants or by new routes of application like the intradermal vaccination which produces higher antibody levels. Invasive pneumococcal infections cause up to 10000 deaths in Germany every year. The polysaccharide vaccine prevents 60 - 80 % of invasive bacteremic pneumococcal infections and reduces the mortality and severity of invasive courses. Only 20 % of the target group is vaccinated: German physicians should stress the need for pneumococcal vaccination.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Weinke</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Zentrum für Innere Medizin, Klinikum Ernst von Bergmann, Potsdam. tweinke@klinikumevb.de</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Güthoff</LastName><ForeName>W</ForeName><Initials>W</Initials></Author></AuthorList><Language>ger</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Grippe- und Pneumokokkenimpfung im Erwachsenenalter.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2009</Year><Month>04</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Dtsch Med Wochenschr</MedlineTA><NlmUniqueID>0006723</NlmUniqueID><ISSNLinking>0012-0472</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D022242">Pneumococcal Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000917" MajorTopicYN="N">Antibody Formation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016470" MajorTopicYN="N">Bacteremia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005858" MajorTopicYN="N" Type="Geographic">Germany</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010817" MajorTopicYN="N">Physician-Patient Relations</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D022242" MajorTopicYN="N">Pneumococcal Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012621" MajorTopicYN="N">Seasons</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>4</Month><Day>9</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>4</Month><Day>16</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2009</Year><Month>5</Month><Day>15</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19353477</ArticleId><ArticleId IdType="doi">10.1055/s-0029-1220215</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/GrippeAllemagneV3/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000415 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000415 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= GrippeAllemagneV3
|flux= Main
|étape= Corpus
|type= RBID
|clé= pubmed:19353477
|texte= [Influenza and pneumococcal vaccination in adults].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:19353477" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a GrippeAllemagneV3
| This area was generated with Dilib version V0.6.35. |  |